Literature DB >> 26409702

Clinical Exome Sequencing as a Novel Tool for Diagnosing Loeys-Dietz Syndrome Type 3.

A Blinc1, A Maver2, G Rudolf2, J Tasič3, J Pretnar Oblak4, P Berden5, B Peterlin6.   

Abstract

OBJECTIVE/
BACKGROUND: In rare genetic vascular syndromes the diagnosis may not be apparent from the phenotype, but might be important for proper management.
METHODS: A previously healthy woman without dysmorphic features presented with pregnancy associated vascular dissections and aneurysms. Next generation clinical exome sequencing was performed.
RESULTS: The differential diagnosis of spontaneous arterial dissection is outlined. The patient's diagnosis became evident after clinical exome sequencing detected a novel missense mutation in the evolutionary conserved region of SMAD3, confirming the diagnosis of Loeys-Dietz syndrome (LDS) type 3. A brief overview of the various types of LDS and their management is presented.
CONCLUSION: Clinical exome sequencing proved useful in diagnosing LDS type 3 where detailed vascular surveillance and timely intervention with a low threshold is recommended.
Copyright © 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aneurysm; Clinical exome sequencing; Loeys-Dietz syndrome; Pregnancy; Spontaneous arterial dissection

Mesh:

Substances:

Year:  2015        PMID: 26409702     DOI: 10.1016/j.ejvs.2015.08.003

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

1.  Coronary artery aneurysm in Loeys-Dietz syndrome: a case report.

Authors:  Zachary T Jost; Charlie J Sang; Pongtawat Lertwilaiwittaya; Gregory D Chapman
Journal:  Eur Heart J Case Rep       Date:  2022-05-13

2.  Novel SMAD3 p.Arg386Thr genetic variant co-segregating with thoracic aortic aneurysm and dissection.

Authors:  Karolina Engström; Farkas Vánky; Malin Rehnberg; Cecilia Trinks; Jon Jonasson; Anna Green; Cecilia Gunnarsson
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

3.  A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3.

Authors:  Dorien Schepers; Giada Tortora; Hiroko Morisaki; Gretchen MacCarrick; Mark Lindsay; David Liang; Sarju G Mehta; Jennifer Hague; Judith Verhagen; Ingrid van de Laar; Marja Wessels; Yvonne Detisch; Mieke van Haelst; Annette Baas; Klaske Lichtenbelt; Kees Braun; Denise van der Linde; Jolien Roos-Hesselink; George McGillivray; Josephina Meester; Isabelle Maystadt; Paul Coucke; Elie El-Khoury; Sandhya Parkash; Birgitte Diness; Lotte Risom; Ingrid Scurr; Yvonne Hilhorst-Hofstee; Takayuki Morisaki; Julie Richer; Julie Désir; Marlies Kempers; Andrea L Rideout; Gabrielle Horne; Chris Bennett; Elisa Rahikkala; Geert Vandeweyer; Maaike Alaerts; Aline Verstraeten; Hal Dietz; Lut Van Laer; Bart Loeys
Journal:  Hum Mutat       Date:  2018-03-06       Impact factor: 4.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.